Neurocrine Biosciences | Marktkapitalisierung

Market Capitalization Veränderung Datum
Acadia Pharmaceuticals USD 5.14B 1.73B 2023-12
Agios Pharmaceuticals USD 1.25B 135M 2023-12
Alnylam Pharmaceuticals USD 24.02B 1.88B 2023-12
Amgen USD 154.14B 10.38B 2023-12
Cytokinetics USD 8.19B 5.36B 2023-12
Dynavax Technologies USD 1.9B 242M 2023-09
Gilead Sciences USD 100.94B 7.57B 2023-12
Halozyme Therapeutics USD 4.88B 157M 2023-12
Intra Cellular Therapies USD 6.67B 227M 2024-03
Ionis Pharmaceuticals USD 6.19B 1.07B 2024-03
Regeneron Pharmaceuticals USD 106.74B 11.05B 2024-03
Teva Pharmaceutical Industries ILS 42.76B 315.46M 2023-12
Ultragenyx Pharmaceutical USD 3.77B 153M 2024-03
Vertex Pharmaceuticals USD 106.53B 1.68B 2024-03



Neurocrine Biosciences Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2024.